|
Age, median (range)
|
56 (18–87)
|
54 (19–89)
|
0.898
|
|
Men/women
|
337/300
|
37/32
|
0.900
|
|
Hemoglobin, g/L, median (range)
|
124 (51–172)
|
117 (87–141)
|
0.017
|
|
Leukocytes, ×109/L, median (range)
|
7.4 (0.4–28.5)
|
8.5 (4.6–16.6)
|
0.132
|
|
Platelets, ×109/L, median (range)
|
248 (29–613)
|
283 (103–678)
|
0.034
|
|
NLR, median (range)
|
2.7 (0.2–32.5)
|
3.79 (0.7–160.5)
|
0.001
|
|
PLR, median (range)
|
10.1 (0.3–193.3)
|
14.5 (483.3)
|
0.001
|
|
ESR, mm/h, median (range)
|
26 (2–150)
|
38 (2–150)
|
0.023
|
|
CRP, mg/L, median (range)
|
9.9 (0.1–274.6)
|
30.6 (0.8–251.8)
|
< 0.001
|
|
Fibrinogen, mg/L, median (range)
|
5.3 (1–13.2)
|
5.7 (1.9–11.8)
|
0.351
|
|
LDH > reference range limit, n (%)
|
187 (30.4)
|
32 (50.8)
|
0.001
|
|
TP < reference range limit, n (%)
|
258 (40.5)
|
39 (56.6)
|
0.024
|
|
Albumin < reference range limit, n (%)
|
70 (11)
|
15 (21.2)
|
0.032
|
|
B symptomatology, n (%)
|
360 (56.6)
|
52 (75.4)
|
0.001
|
|
“Bulky” tumor mass, n (%)
|
182 (28.5)
|
34 (49.3)
|
< 0.001
|
|
Extranodal localization, n (%)
|
368 (57.8)
|
35 (50.7)
|
0.259
|
|
Mediastinal involvement, n (%)
|
189 (29.6)
|
32 (46.4)
|
0.004
|
|
IPI > 1, n (%)
|
153 (52.0)
|
27 (71.1)
|
0.027
|
